📢 Big news! We are delighted to announce our partnership with Cerba HealthCare, a European leader in medical diagnostics. GMT Science joins Cerba HealthCare virtual incubator to accelerate the development of its microbiome-based in vitro diagnostics in oncology and cardiometabolic diseases.

We are pleased to share our latest publication describing a new methodology for assessing metagenomic pipelines, designed to objectively compare taxonomic profiling tools.

Accurate microbiome analysis is key for basic and clinical research, and for industrial applications.
t.ly/9TNma